Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lung Neoplasms"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 110746
Tytuł:
Lung cancer screening an asbestos exposed population: Existing lung cancer risk criteria are not sufficient.
Autorzy:
Brims FJH; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.; Curtin Medical School, Curtin University, Perth, Western Australia, Australia.; National Centre for Asbestos Related Diseases, Institute for Respiratory Health, Perth, Western Australia, Australia.
Harris EJA; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.; Curtin Medical School, Curtin University, Perth, Western Australia, Australia.
Murray C; ChestRad Medical Imaging, Perth, Western Australia, Australia.
Kumarasamy C; Curtin Medical School, Curtin University, Perth, Western Australia, Australia.
Ho A; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
Adler B; Envision Medical Imaging, Perth, Western Australia, Australia.
Franklin P; School of Global and Population Health, University of Western Australia, Perth, Western Australia, Australia.
de Klerk NH; School of Global and Population Health, University of Western Australia, Perth, Western Australia, Australia.
Pokaż więcej
Źródło:
Respirology (Carlton, Vic.) [Respirology] 2023 Jun; Vol. 28 (6), pp. 543-550. Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/epidemiology
Asbestos*/adverse effects
Humans ; Male ; Aged ; Female ; Early Detection of Cancer/methods ; Risk Factors ; Lung/diagnostic imaging ; Mass Screening/adverse effects
Czasopismo naukowe
Szczegóły
Tytuł:
Decision Regret among Patients with Early-stage Lung Cancer Undergoing Radiation Therapy or Surgical Resection.
Autorzy:
Sullivan DR; Division of Pulmonary & Critical Care Medicine (PCCM), OHSU, Portland, OR, USA; Center to Improve Veteran Involvement in Care (CIVIC), VA-Portland Health Care System (VAPORHCS), Portland, OR, USA; Knight Cancer Institute, OHSU, Portland, OR, USA. Electronic address: .
Wisnivesky JP; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Division of PCCM Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Nugent SM; Center to Improve Veteran Involvement in Care (CIVIC), VA-Portland Health Care System (VAPORHCS), Portland, OR, USA; Knight Cancer Institute, OHSU, Portland, OR, USA.
Stone K; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Division of PCCM Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Farris MK; Department of Radiation Oncology, Wake Forest Baptist Atrium Health, Winston-Salem, NC, USA.
Kern JA; Division of Oncology, National Jewish Health, Denver, CO, USA.
Swanson S; Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Division of Surgical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Smith CB; Division of Hematology and Medical Oncology, Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Rosenzweig K; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Slatore CG; Division of Pulmonary & Critical Care Medicine (PCCM), OHSU, Portland, OR, USA; Center to Improve Veteran Involvement in Care (CIVIC), VA-Portland Health Care System (VAPORHCS), Portland, OR, USA; Knight Cancer Institute, OHSU, Portland, OR, USA; Section of PCCM, VAPORHCS, Portland, OR, USA.
Pokaż więcej
Źródło:
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2023 Jun; Vol. 35 (6), pp. e352-e361. Date of Electronic Publication: 2023 Mar 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/surgery
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Radiosurgery*/adverse effects
Humans ; Female ; Aged ; Male ; Prospective Studies ; Treatment Outcome ; Emotions ; Neoplasm Staging
Czasopismo naukowe
Szczegóły
Tytuł:
Effect of an artificial intelligence tool on management decisions for indeterminate pulmonary nodules.
Autorzy:
Kim RY; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Oke JL; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Dotson TL; Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Bellinger CR; Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Vachani A; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
Respirology (Carlton, Vic.) [Respirology] 2023 Jun; Vol. 28 (6), pp. 582-584. Date of Electronic Publication: 2023 Apr 05.
Typ publikacji:
Letter
MeSH Terms:
Multiple Pulmonary Nodules*/diagnostic imaging
Multiple Pulmonary Nodules*/therapy
Lung Neoplasms*/diagnosis
Lung Neoplasms*/therapy
Humans ; Artificial Intelligence
Opinia redakcyjna
Szczegóły
Tytuł:
Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules.
Autorzy:
Peters AA; Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany. .; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Im Neuenheimer Feld 156, 69120, Heidelberg, Germany. .; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Röntgenstraße 1, 69126, Heidelberg, Germany. .; Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse, 3010, Bern, Switzerland. .
Weinheimer O; Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Im Neuenheimer Feld 156, 69120, Heidelberg, Germany.
von Stackelberg O; Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Im Neuenheimer Feld 156, 69120, Heidelberg, Germany.
Kroschke J; Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Im Neuenheimer Feld 156, 69120, Heidelberg, Germany.; Institute for Radiology, Kantonsspital Thurgau, Spitalcampus 1, 8596, Münsterlingen, Switzerland.
Piskorski L; Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Im Neuenheimer Feld 156, 69120, Heidelberg, Germany.
Debic M; Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Im Neuenheimer Feld 156, 69120, Heidelberg, Germany.
Schlamp K; Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Röntgenstraße 1, 69126, Heidelberg, Germany.
Welzel L; Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Im Neuenheimer Feld 156, 69120, Heidelberg, Germany.
Pohl M; Institute of Medical Biometry, University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
Christe A; Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse, 3010, Bern, Switzerland.
Ebner L; Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse, 3010, Bern, Switzerland.
Kauczor HU; Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Im Neuenheimer Feld 156, 69120, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Röntgenstraße 1, 69126, Heidelberg, Germany.
Heußel CP; Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Im Neuenheimer Feld 156, 69120, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Röntgenstraße 1, 69126, Heidelberg, Germany.
Wielpütz MO; Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Im Neuenheimer Feld 156, 69120, Heidelberg, Germany.; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Röntgenstraße 1, 69126, Heidelberg, Germany.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 Jun; Vol. 33 (6), pp. 3908-3917. Date of Electronic Publication: 2022 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
Solitary Pulmonary Nodule*/diagnostic imaging
Solitary Pulmonary Nodule*/pathology
Multiple Pulmonary Nodules*/diagnostic imaging
Multiple Pulmonary Nodules*/pathology
Pulmonary Emphysema*/diagnostic imaging
Pulmonary Emphysema*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Emphysema*
Female ; Humans ; Aged ; Male ; Retrospective Studies ; Lung/diagnostic imaging ; Lung/pathology ; Tomography, X-Ray Computed/methods ; Fibrosis
Czasopismo naukowe
Szczegóły
Tytuł:
A pre-treatment CT-based weighted radiomic approach combined with clinical characteristics to predict durable clinical benefits of immunotherapy in advanced lung cancer.
Autorzy:
Zhu Z; Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.; 4+4 Medical Doctor Program, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
Chen M; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Hu G; Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Pan Z; Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.; 4+4 Medical Doctor Program, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
Han W; Department of Epidemiology and Biostatistics, Institute of Basic Medicine Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.
Tan W; Deepwise Artificial Intelligence (AI) Lab, Beijing Deepwise & League of PhD technology Co. Ltd, Beijing, 100080, China.
Zhou Z; Deepwise Artificial Intelligence (AI) Lab, Beijing Deepwise & League of PhD technology Co. Ltd, Beijing, 100080, China.
Wang M; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Mao L; Deepwise Artificial Intelligence (AI) Lab, Beijing Deepwise & League of PhD technology Co. Ltd, Beijing, 100080, China.
Li X; Deepwise Artificial Intelligence (AI) Lab, Beijing Deepwise & League of PhD technology Co. Ltd, Beijing, 100080, China.
Sui X; Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Song L; Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. .
Xu Y; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. .
Song W; Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. .
Yu Y; Department of Computer Science, The University of Hong Kong, Hong Kong, China.
Jin Z; Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 Jun; Vol. 33 (6), pp. 3918-3930. Date of Electronic Publication: 2022 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/therapy
Humans ; Retrospective Studies ; Kaplan-Meier Estimate ; Tomography, X-Ray Computed/methods ; Immunotherapy/methods
Czasopismo naukowe
Szczegóły
Tytuł:
Improving the efficiency of identifying malignant pulmonary nodules before surgery via a combination of artificial intelligence CT image recognition and serum autoantibodies.
Autorzy:
Ding Y; Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No.106, Zhongshan 2nd Road, Guangzhou, 510080, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Zhang J; State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, No. 1, Medical College Road, Yuzhong District, Chongqing, 400016, China.
Zhuang W; Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No.106, Zhongshan 2nd Road, Guangzhou, 510080, China.
Gao Z; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Kuang K; Dianei Technology, Shanghai, China.
Tian D; Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No.106, Zhongshan 2nd Road, Guangzhou, 510080, China.
Deng C; Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No.106, Zhongshan 2nd Road, Guangzhou, 510080, China.
Wu H; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.; Department of Thoracic Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Chen R; Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Lu G; Department of Thoracic Surgery, Guangzhou Panyu Central Hospital, Guangzhou, China.
Chen G; Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No.106, Zhongshan 2nd Road, Guangzhou, 510080, China.
Mendogni P; Thoracic Surgery and Lung Transplant Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Migliore M; Thoracic Surgery, Cardio-Thoracic Department, University Hospital of Wales, Cardiff, UK.; Minimally Invasive Surgery and New Technology, University Hospital of Catania, Department of Surgery and Medical Specialties, University of Catania, Catania, Italy.
Kang MW; Department of Thoracic and Cardiovascular Surgery, Chungnam National University School of Medicine, Daejeon, South Korea.
Kanzaki R; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Tang Y; Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No.106, Zhongshan 2nd Road, Guangzhou, 510080, China.
Yang J; Dianei Technology, Shanghai, China.; Computer Vision Laboratory (CVLab), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Shi Q; State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, No. 1, Medical College Road, Yuzhong District, Chongqing, 400016, China. .
Qiao G; Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No.106, Zhongshan 2nd Road, Guangzhou, 510080, China. .; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 May; Vol. 33 (5), pp. 3092-3102. Date of Electronic Publication: 2022 Dec 08.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/surgery
Multiple Pulmonary Nodules*/diagnostic imaging
Multiple Pulmonary Nodules*/surgery
Humans ; Artificial Intelligence ; Autoantibodies ; Tomography, X-Ray Computed/methods ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Facilitating combined biopsy and percutaneous microwave ablation of pulmonary ground-glass opacities using lipiodol localisation.
Autorzy:
Meng M; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, 250021, Shandong Province, China.
Huang G; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, 250021, Shandong Province, China.
Wang J; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, 250021, Shandong Province, China.
Li W; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, 250021, Shandong Province, China.
Ni Y; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, 250021, Shandong Province, China.
Zhang T; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, 250021, Shandong Province, China.
Han X; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, 250021, Shandong Province, China.
Dai J; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, 250021, Shandong Province, China.
Zou Z; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, 250021, Shandong Province, China.
Yang X; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, 250021, Shandong Province, China. yangxia_.
Ye X; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University, 16766 Jingshi Road, Jinan, 250014, Shandong Province, China. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 May; Vol. 33 (5), pp. 3124-3132. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Catheter Ablation*/methods
Humans ; Ethiodized Oil ; Retrospective Studies ; Microwaves/therapeutic use ; Biopsy ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
[Expert consensus on the diagnosis and treatment in advanced non-small cell lung cancer with BRAF mutation in China].
Corporate Authors:
Lung Cancer Professional Committee of Chinese Anti-Cancer Association
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Apr 23; Vol. 45 (4), pp. 279-290.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Proto-Oncogene Proteins B-raf/genetics ; Consensus ; Mutation
Czasopismo naukowe
Szczegóły
Tytuł:
[Ceritinib as First-line Treatment for Advanced Lung Adenocarcinoma 
with COX7A2L-ALK Fusion: A Case Report and Literature Review].
Autorzy:
Yuan J; Department of Respiratory Disease, Chengdu Seventh People's Hospital, Chengdu 610213, China.; Department of Pulmonary and Critic Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinses Academy of Medical Science, Beijing 100730, China.
Pan R; Department of Pulmonary and Critic Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinses Academy of Medical Science, Beijing 100730, China.
Zhong W; Department of Pulmonary and Critic Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinses Academy of Medical Science, Beijing 100730, China.
Wang M; Department of Pulmonary and Critic Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinses Academy of Medical Science, Beijing 100730, China.
Pokaż więcej
Źródło:
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2023 Apr 20; Vol. 26 (4), pp. 319-324.
Typ publikacji:
Review; Case Reports; English Abstract; Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/diagnosis
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Humans ; Anaplastic Lymphoma Kinase/genetics ; Crizotinib ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/pharmacology ; Oncogene Proteins, Fusion/genetics
Czasopismo naukowe
Szczegóły
Tytuł:
[Advances in Diagnosis and Treatment of HER2-positive Non-small Cell Lung Cancer].
Autorzy:
Ren C; Department of Respiratory Disease, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China.
Cao H; Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.
Zheng J; Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.
Sun W; Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.
Zhou J; Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.
Pokaż więcej
Źródło:
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2023 Apr 20; Vol. 26 (4), pp. 291-302.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Antineoplastic Agents*/therapeutic use
Antineoplastic Agents*/pharmacology
Humans ; Receptor, ErbB-2/genetics ; Mutation ; Signal Transduction ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
[Cigarette Smoke Induces Gefitinib Resistance in NSCLC Cells 
via ROS/Sirt3/SOD2 Pathway].
Autorzy:
Zi Y; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.; Chongqing Key Laboratory of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Liao K; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Chen H; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Pokaż więcej
Źródło:
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2023 Apr 20; Vol. 26 (4), pp. 245-256.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/metabolism
Sirtuin 3*/genetics
Sirtuin 3*/therapeutic use
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Antineoplastic Agents*/therapeutic use
Cigarette Smoking*
Humans ; Gefitinib/pharmacology ; Gefitinib/therapeutic use ; Reactive Oxygen Species/metabolism ; Reactive Oxygen Species/therapeutic use ; Sincalide/therapeutic use ; ErbB Receptors/metabolism ; Drug Resistance, Neoplasm/genetics ; Cell Line, Tumor
Czasopismo naukowe
Szczegóły
Tytuł:
[Early Onset Pulmonary Events and Management Strategies during the Treatment of 
ALK Positive NSCLC Patients with Brigatinib].
Autorzy:
Yang M; School of Medicine South China University of Technology, Guangzhou 510080, China.; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Southern Medical University, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
Luo W; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Southern Medical University, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
Zhou Q; School of Medicine South China University of Technology, Guangzhou 510080, China.; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Southern Medical University, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
Pokaż więcej
Źródło:
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2023 Apr 20; Vol. 26 (4), pp. 281-290.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Quality of Life ; Receptor Protein-Tyrosine Kinases ; Protein Kinase Inhibitors/adverse effects
Czasopismo naukowe
Szczegóły
Tytuł:
[Advances in Molecular Subtyping, Characteristics and Therapeutic Strategies of 
Small Cell Lung Cancer].
Autorzy:
Wu Y; School of Medicine, Tsinghua University, Beijing 100084, China.
Zhao J; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
Wang M; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
Pokaż więcej
Źródło:
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2023 Apr 20; Vol. 26 (4), pp. 303-309.
Typ publikacji:
Review; English Abstract; Journal Article
MeSH Terms:
Small Cell Lung Carcinoma*/diagnosis
Small Cell Lung Carcinoma*/genetics
Small Cell Lung Carcinoma*/therapy
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/therapy
Animals ; Immunotherapy ; Prognosis
Czasopismo naukowe
Szczegóły
Tytuł:
The Additive Impact of Transbronchial Cryobiopsy Using a 1.1-mm Diameter Cryoprobe on Conventional Biopsy for Peripheral Lung Nodules.
Autorzy:
Kim SH; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
Mok J; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
Jo EJ; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Kim MH; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Lee K; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Kim KU; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Park HK; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Lee MK; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Eom JS; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Apr; Vol. 55 (2), pp. 506-512. Date of Electronic Publication: 2022 Nov 01.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnosis
Lung Neoplasms*/pathology
Humans ; Retrospective Studies ; Biopsy/adverse effects ; Bronchoscopy/adverse effects ; Lung/diagnostic imaging ; Lung/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Real World Characteristics and Clinical Outcomes of HER2-Mutant Non-Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing.
Autorzy:
Ahn BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Han YJ; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Hong MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Lim SM; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Apr; Vol. 55 (2), pp. 488-497. Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Antineoplastic Agents*/therapeutic use
Humans ; Female ; Middle Aged ; Male ; Retrospective Studies ; Mutation ; High-Throughput Nucleotide Sequencing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer.
Autorzy:
Lu J; National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Li J; National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Lin Z; National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Li H; National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Lou L; National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Ding W; National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Ouyang S; National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Wu Y; Department of Thoracic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Wen Y; Increasepharm (Hengqin) Innovative Medicine Institute Co. Ltd, Zhuhai, 519000, China.
Chen X; Increasepharm (Hengqin) Innovative Medicine Institute Co. Ltd, Zhuhai, 519000, China.
Yue P; Department of Medicine, Division of Hematology-Oncology, and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Wang Y; National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Liu P; National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
Lu J; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, 519000, Macau. Electronic address: .
Zhang J; Department of Thoracic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China. Electronic address: .
Feng W; Department of Head and Neck/Thoracic Medical Oncology, The First People's Hospital of Foshan, Foshan, 52800, China. Electronic address: .
Zhang X; National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2023 Jun 28; Vol. 564, pp. 216205. Date of Electronic Publication: 2023 May 04.
Typ publikacji:
Journal Article
MeSH Terms:
ErbB Receptors*/metabolism
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Gefitinib/pharmacology ; Gefitinib/therapeutic use ; Tumor-Associated Macrophages/metabolism ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Drug Resistance, Neoplasm ; Cell Line, Tumor ; Tumor Microenvironment ; STAT3 Transcription Factor/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Targeted therapy for lung cancer: Beyond EGFR and ALK.
Autorzy:
Herrera-Juárez M; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital Universitario 12 de Octubre, Madrid, Spain.
Serrano-Gómez C; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Bote-de-Cabo H; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital Universitario 12 de Octubre, Madrid, Spain.
Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, Complutense University, Madrid, Spain.
Pokaż więcej
Źródło:
Cancer [Cancer] 2023 Jun 15; Vol. 129 (12), pp. 1803-1820. Date of Electronic Publication: 2023 Apr 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Humans ; Anaplastic Lymphoma Kinase/genetics ; Mutation ; Precision Medicine ; ErbB Receptors/genetics ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Molecular Targeted Therapy
Czasopismo naukowe
Szczegóły
Tytuł:
Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non-small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy.
Autorzy:
Chu T; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yuan J; Geneplus-Shenzhen, Shenzhen, China.
Lu J; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Translational Medical Research Platform for Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Department of Bio-Bank, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Nie W; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhong R; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang B; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang W; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shi C; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qian J; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang Y; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang X; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Teng J; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gao Z; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lou Y; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Li J; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qiang H; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang C; Geneplus-Shenzhen, Shenzhen, China.
Li J; Geneplus-Shenzhen, Shenzhen, China.
Xia X; Geneplus-Beijing, Beijing, China.
Zhong H; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Han B; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jun; Vol. 13 (6), pp. e1277.
Typ publikacji:
Letter
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Treatment Outcome
Opinia redakcyjna
Szczegóły
Tytuł:
Multicomponent mathematical model for tumor volume calculation with setup error using single-isocenter stereotactic radiotherapy for multiple brain metastases.
Autorzy:
Nakano H; Department of Radiation Oncology, Niigata University Medical and Dental Hospital, 1-757 Asahimachi-Dori, Chuo-Ku, Niigata-Shi, Niigata, Japan. .; Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-Shi, Osaka, Japan. .
Shiinoki T; Department of Radiation Oncology, Yamaguchi University, Minamikogushi 1-1-1 Ube, Yamaguchi, Japan.
Tanabe S; Department of Radiation Oncology, Niigata University Medical and Dental Hospital, 1-757 Asahimachi-Dori, Chuo-Ku, Niigata-Shi, Niigata, Japan.
Nakano T; Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-Ku, Niigata-Shi, Niigata, Japan.
Takizawa T; Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-Ku, Niigata-Shi, Niigata, Japan.; Department of Radiation Oncology, Niigata Neurosurgical Hospital, 3057 Yamada, Nishi-Ku, Niigata-Shi, Niigata, Japan.
Utsunomiya S; Department of Radiological Technology, Niigata University Graduate School of Health Sciences, 2-746 Asahimachi-Dori, Chuo-Ku, Niigata-Shi, Niigata, Japan.
Sakai M; Department of Radiation Oncology, Niigata University Medical and Dental Hospital, 1-757 Asahimachi-Dori, Chuo-Ku, Niigata-Shi, Niigata, Japan.
Tanabe S; Department of Radiation Oncology, Niigata University Medical and Dental Hospital, 1-757 Asahimachi-Dori, Chuo-Ku, Niigata-Shi, Niigata, Japan.
Ohta A; Department of Radiation Oncology, Niigata University Medical and Dental Hospital, 1-757 Asahimachi-Dori, Chuo-Ku, Niigata-Shi, Niigata, Japan.
Kaidu M; Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-Ku, Niigata-Shi, Niigata, Japan.
Nishio T; Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-Shi, Osaka, Japan.
Ishikawa H; Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-Ku, Niigata-Shi, Niigata, Japan.
Pokaż więcej
Źródło:
Physical and engineering sciences in medicine [Phys Eng Sci Med] 2023 Jun; Vol. 46 (2), pp. 945-953. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/radiotherapy
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/radiotherapy
Brain Neoplasms*/secondary
Humans ; Tumor Burden ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted ; Models, Theoretical
Czasopismo naukowe
Szczegóły
Tytuł:
Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas.
Autorzy:
Goldschmid H; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Kluck K; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Ball M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany.
Kirchner M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Allgäuer M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Winter H; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; Department of Thoracic Surgery, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Herth F; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; Department of Pulmonology, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Heußel CP; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Pullamsetti SS; Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Savai R; Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany; Institute for Lung Health (ILH), Justus Liebig University, Giessen, Germany.
Yong TTK; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Department of Anatomical Pathology, Department of Molecular Pathology at Singapore General Hospital, Singapore.
Schirmacher P; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Center for Personalized Medicine Heidelberg (ZPM), Heidelberg, Germany.
Peters S; Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.
Thomas M; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; Department of Thoracic Oncology, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Christopoulos P; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; Department of Thoracic Oncology, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Budczies J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: .
Kazdal D; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany. Electronic address: .
Pokaż więcej
Źródło:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Jun; Vol. 180, pp. 107212. Date of Electronic Publication: 2023 Apr 23.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/immunology
Adenocarcinoma of Lung*/therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/immunology
Lung Neoplasms*/therapy
Immune Evasion*/genetics
AMP-Activated Protein Kinase Kinases*/genetics
Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology ; Humans ; Mutation ; Neoplasm Staging
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 110746

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies